Gold is known as an attractive safe-haven investment and has been used to store wealth during volatile times through history. It has interesting currency-like tendencies, and retains its purchasing power better than paper currencies. For...
Retailers like ANF, URBN, CASY & DLTR that focus on competitive pricing and product innovation may witness higher foot traffic and better conversion rates.
Providence Gold Mines Inc. ( “the Company) is pleased to announce further to the Private placement announced on November 14, 2024 that an insider of the Company is participating in the first tranche of the private placement in the amount...
Although SLB is making substantial investments in digital transformation and AI-driven solutions, these efforts have yet to result in notable revenue growth.
BNPL may not technically be credit, but it's still debt that can become a financial burden before you know it. Meredith has a list of "Dos" and "Don'ts" that will help you enjoy the benefits of this option without paying for it well into...
ENSG drives revenue growth through advanced healthcare services, strategic acquisitions, and rental income from triple-net leases, supported by strong cash reserves and a 21-year dividend growth streak.
Australian lithium company Sayona Mining (ASX: SYA ,OTCQB:SYAXF) and US-based Piedmont Lithium ( ASX: PLL , NASDAQ:PLL) have announced a merger agreement that would create a consolidated entity valued at approximately US$623 million....
Investor Insight Osisko Metals’ high-quality polymetallic assets present a compelling investment opportunity amid a rapidly expanding critical and base metals market, as North America continues to strengthen its domestic supply....
YPF Sociedad Anonima's Vaca Muerta Sur project is aimed at increasing Argentina's export capacity and positioning the country as a major oil exporter in South America.
Canadian Imperial Bank (CM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Following the FDA's approval, Jazz's Ziihera becomes the first dual HER2-targeted bispecific antibody and chemotherapy-free treatment approved for biliary tract cancer.